Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 003022.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 29.45 0.91 0.70
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 48.87 55.94 37.58
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.76 5.37 5.33
Cash 45.18 2.72 1.87
Capex 45.70 -0.40 -0.73
Free Cash Flow -9.54 -0.38 -0.35
Revenue -19.26 1.10 1.37
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 56.29 0.16 0.10
Operating Margin 191.06 0.02 < 0.005
ROA 13.66 < 0.005 < 0.005
ROE 22.26 < 0.005 < 0.005
ROIC 51.83 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 003022.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 003022.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 003022.SZ is permitted for members.